Substance Use Disorders

Similar documents
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی

Neurobiology of Drug Abuse and Addiction PSYC 450

Opioid Use Issues: All the Players

_._ L.---l Alcohol Use Disorder'': b (490) Speciftj current severity: (FiO.10) Mild (F10.20) (1=10.20)

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH

Factors Influencing Health

Important Information

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

Commi ee Lecture: Neurocogni ve Disorders TBI : Trauma c Brain Disorders. William L. Bograkos, MA, DO, FACOEP

PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management. AD ICD-10-CM Frequently Asked Questions

Clinical Evaluation: Assessment Goals

Opiate Use Disorder and Opiate Overdose

Feeding and Eating Disorders

Chapter 7. Screening and Assessment

Appendix F Federation of State Medical Boards

A look at Marijuana in 2014

substance use and mental disorders: one, the other, or both?

Clinical and public health significance of the proposed changes to the diagnosis of alcohol abuse and dependence in DSM-5

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

DSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION

FAA Policy and Regulations. Agenda

Acute General Medical and Surgical Admission:

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

12/26/ Fear of the unknown prevents one from embracing the future.

FAA Medical Certification

Common Diagnosis Codes and Tips for Coding Nicotine Use/

MASS COMMUNICATIONS The traditional realm of mass communications includes television,

Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %

Critiquing the Construction of Addiction: Dependence, Disorder and the DSM V

Session Guidelines. This is a 15 minute webinar session for CNC physicians and staff

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Survey of Temporary Assistance For Needy Families (TANF) Recipients

2/21/2018. What are Opioids?

Proposed Revision to Med (i)

FOUR SELF-TESTS: SEXUAL ADDICTION, SEXUAL ANOREXIA, BINGE-PURGE, COLLATERAL INDICATORS

Substance Use and Addictive Disorders

NEW AND REVISED DSM DISORDERS. Disruptive Mood Dysregulation Disorder Autism Spectrum Disorders Substance Use Disorders

The Role of the PDMP: Foundational Knowledge and Best Practices

Module Three Screening and Assessment V

Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD

Prescription Drug Monitoring and Toxicology ICD-10-CM. resource guide. Provided as a service of Quest Diagnostics. 1 ICD-10-CM Resource Guide

DSM-5 Table of Contents

SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS

INDIANA HEALTH COVERAGE PROGRAMS

Classification of Abuse-Related Events in Analgesic Clinical Trials: Recommendations and Research Agenda

Overview. APPLIED PREVENTION & intervention STRATEGIES. APPLIED PREVENTION & intervention STRATEGIES

SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION

History of Present Illness (HPI) Assessment and Plan Template

Profile of PAES Recipients and Factors That Influence PAES Outcomes

ICD-10-CM Resource Guide

Hot Topics in Addiction Medicine. Timothy Fong MD 44 th Annual Family Medicine Refresher March 2017

Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders

THE ADDICTIVE BRAIN SC 212 JANUARY 3, 2017 JOHN BUSH

*Many of these DSM 5 Diagnoses might also be used to argue for eligibility using Other Health Impaired Criteria

Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com

PSYCHOPATHOLOGY, DIFFERENTIAL DIAGNOSIS, AND THE DSM-5: A COMPREHENSIVE OVERVIEW

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

A Comprehensive Model of Stepped Care for Substance Misuse Prevention on a College Campus

Today s Presenter 4/22/2015. ICD-10-CM Documentation and Diagnosis: Behavioral Health. By Tammy Jones, CPC, COC

Initial Substance Use Assessment

Psychosis, Mood, and Personality: A Clinical Perspective

Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

March 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York

Polysubstance Use & Medication-Assisted Treatment

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

INDIANA HEALTH COVERAGE PROGRAMS

PRACTICE ALERT. New ICD Code Changes. Mirean Coleman, LICSW, CT Clinical Manager. December 2017

Alcohol Misuse Clinical Pathway Outline

SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

KAP Keys. For Clinicians. Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians. CSAT s Knowledge Application Program

THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved

Running head: DEPRESSIVE DISORDERS 1

Mental Health Nursing: Substance-Related Disorders. By Mary B. Knutson, RN, MS, FCP

SWK 3805: Module 2- Introducing Theories of Addiction

Neoplasms/Lymphoma/Leukemia

Substance Abuse Level of Care Criteria

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

Table of substance use disorder diagnoses:

Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD

ADDICTIONS. Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry

MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES

Tapering Opioids Best Practices*

Adolescents And Addiction

Marijuana. Marijuana (Cannabis Use Disorder) Learning Goals/Objectives

Addiction: definition and implications

Understanding Drug and Alcohol Abuse and Addiction

Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11

Alcohol & Drug Use: Roadmap to Certification

A substance that reduces pain and may or may not have psychoactive properties.

Comorbidity of Substance Use Disorders and Psychiatric Conditions-2

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

BASIC VOLUME. Elements of Drug Dependence Treatment

Transcription:

Substance Use Disorders

Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and coding Next scheduled webinar: November Topic: Diabetic Complications CNC does not accept responsibility or liability for any adverse outcome from this training for any reason including undetected inaccuracy, opinion, and analysis that might prove erroneous or amended, or the coder/physician s misunderstanding or misapplication of topics. Application of the information in this training does not imply or guarantee claims payment.

Substance Use Disorder Use is irregular or low frequency use of a substance that is not habitual Abuse is habitual use of a substance that negatively impacts a patient s health or social functioning but has not arrived at the point of physical and/or mental dependency; assigned for mild use disorder Dependence is a chronic mental and physical state where the patient has to use a substance in order to function normally; generally these patients experience signs of withdrawal upon cessation of the substance; assigned for moderate or severe use disorder

Substance Use Disorder Codes from category Z79 indicate a patient s continuous use of a prescribed drug for the long-term treatment of a chronic condition (such as arthritis pain) or for an extended period as a prophylactic measure (such as prevention of DVT). It is appropriate to assign a code from category Z79 if a patient is taking a drug as prescribed and without psychological/physical addiction. This subcategory is not for use of medications for detoxification or maintenance programs to prevent withdrawal symptoms in patients with an established drug dependence diagnosis (e.g. methadone maintenance for heroin addiction or Suboxone for treatment of opioid dependence). Assign the appropriate code for the drug dependence instead. The correct ICD-10-CM codes for long-term use of opiates, sedatives, hypnotics or anxiolytics as part of care for another condition are: Z79.891 Long-term (current) use of opiate analgesic Z79.899 Other long-term (current) drug therapy

Substance Use Disorder DSM V Criteria There are 10 classes of substance use disorders and the diagnosis of substance use disorder can be applied to all 10 classes included in this chapter except caffeine. The nine substance use disorders, not including caffeine, follow the same criteria 1-11 below. Each substance-induced disorder also has specific criteria for each condition. 1. Alcohol 2. Caffeine (only considered a disorder with intoxication or withdrawal) 3. Cannabis 4. Hallucinogens 5. Inhalants 6. Opioids 7. Sedatives, hypnotics, and anxiolytics 8. Stimulants 9. Tobacco (not included for RISK) 10. Other (or unknown) substance

Substance Use Disorder DSM V Criteria Criterion (1-4): Impaired control over substance use 1. Substance are often taken in larger amounts or over a longer period than was intended. 2. There is a persistent desire or unsuccessful efforts to cut down or control substance use. 3. A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects. 4. Craving, or a strong desire or urge to use substance. Criterion (5-7): Social impairment 1. Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home. 2. Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of substance. 3. Important social, occupational, or recreational activities are given up or reduced because of substance use.

Substance Use Disorder DSM V Criteria Criterion (8-9): Risky use of substance 1. Recurrent opioid use in situations in which it is physically hazardous. 2. Continued opioid use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance. Criterion (10-11): Pharmacological criteria 1. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of substance to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of a substance. 2. Withdrawal, as manifested by either of the following: a. The characteristic substance withdrawal syndrome (refer to Criteria A and B of the criteria set for substance withdrawal). b. Substances (or a closely related substance) are taken to relieve or avoid withdrawal symptoms. Note: Neither tolerance or withdrawal is necessary for a diagnosis of substance use disorder. Tolerance & Withdrawal is not considered to be met for those taking prescribed substances solely under appropriate medical supervision. However, prescription medications can be used inappropriately, and a substance use disorder can be correctly diagnosed when there are other symptoms of compulsive, drug seeking behavior.

Substance Use Disorder DSM V Criteria Substance use disorders occur in a broad range of severity, from mild to severe, with severity based on the number of symptom criteria endorsed. As a general estimate of severity: Mild substance use disorder is suggested by the presence of two to three symptoms (codes to Abuse) Moderate by four to five symptoms (codes to Dependence) Severe by six or more symptoms (codes to Dependence) Changing severity across time is also reflected by reductions or increases in the frequency and/or dose of substance use, as assessed by the individual's own report, report of knowledgeable others, clinician's observations, and biological testing.

Substance Induced Disorder DSM V Criteria The following conditions may be classified as substance-induced: 1. Intoxication 2. Withdrawal 3. Other/substance/medication-induced mental disorder 1. Psychotic disorder, bipolar and related disorder, depressive disorder, anxiety disorder, obsessive-compulsive and related disorder, sleep disorder, sexual dysfunction, delirium, and neurocognitive disorders

Substance Induced Disorder Intoxication 1. Criterion A: The essential feature is the development of a reversible substance-specific syndrome due to the recent ingestion of a substance. 2. Criterion B: The clinically significant problematic behavioral or psychological changes associate with intoxication (i.e. mood liability, impaired judgment) are attributable to the physiological effects of the substance on the CNS and develop during or shortly after the use of the substance. 3. Criterion D: The symptoms are not attributable to another medical condition and are not better explained by another mental disorder.

Substance Induced Disorder Withdrawal 1. Criterion A: The essential feature is the development of a substance-specific problematic behavior change, with physiological and cognitive concomitants, that is due to the cessation of, or reduction in, heavy and prolonged substance use. 2. Criterion C: The substance-specific syndrome causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. 3. Criterion D: The symptoms are not attributable to another medical condition and are not better explained by another mental disorder. Note: ICD-10-CM coding rules require that all withdrawal codes imply a comorbid moderate to severe substance use disorder for that substance. If there are symptoms or problems associated with a particular substance, that cause clinically significant distress or impairment in social, occupational or other important areas of functioning, but do not meet the full criteria for any of the substance-specific disorders, the unspecified category can be used (i.e. F12.99 Cannabis use, unspecified with unspecified cannabis-induced disorder)

Substance Induced Disorder Mental Disorders All substance/medication-induced disorders share common characteristics: 1. The disorder represents a clinically significant symptomatic presentation of a relevant mental disorder 2. There is evidence form the history, physical exam, or lab findings of both of the following: 1. The disorder developed during or within 1 month of a substance intoxication or withdrawal or takin a medication; and 2. The involved substance/medication is capable of producing the mental disorder 3. The disorder is not better explained by an independent mental disorder. Such evidence should include: 1. The disorder preceded the onset of severe intoxication or withdrawal or exposer to the medication; or 2. The full mental disorder persisted for substantial period of time (at least 1 month) after the cessation of acute withdrawal or severe intoxication or taking the medication. 4. The disorder does not occur exclusively during the course of a delirium 1. When symptoms are only observed during a delirium, the mental disorder should be diagnosed as delirium. The psychiatric syndrome should not be reported separately. 5. The disorder causes clinically significant distress of impairment in social, occupational, or other important areas of functioning.

Substance Induced Disorder Mental Disorders Substance-induced mental disorders develop in the context of intoxication and withdrawal from substance of abuse, and medication-induced mental disorders are seen with prescribed or over the counter medications that are taken at the suggested doses. Usually temporary and likely to disappear within 1 month or so of cessation of acute withdrawal, severe intoxication, or use of the medication. Exception to these generalizations occur for certain long-duration substance induced disorders: 1. Alcohol-induced neurocognitive disorder 2. Inhalant-induced neurocognitive disorder 3. Sedative, hypnotic, or anxiolytic-induced neurocognitive disorder 4. Hallucinogen persisting perception disorder

ICD-10-CM Guidelines 1. Psychoactive Substance Use, Unspecified 1. As with all other unspecified diagnoses, the codes for unspecified psychoactive substance use (F10.9-, F11.9-, F12.9-, F13.9-, F14.9-, F15.9-, F16.9-, F18.9-, F19.9-) should only be assigned based on provider documentation and when they meet the definition of a reportable diagnosis (see Section III, Reporting Additional Diagnoses). These codes are to be used only when the psychoactive substance use is associated with a physical, mental or behavioral disorder, and such a relationship is documented by the provider.

Questions Please submit coding and documentation questions to RAFeducation@cnchealthplan.com